230 related articles for article (PubMed ID: 27351559)
1. [New treatment options for chronic pruritus].
Zeidler C; Pfleiderer B; Ständer S
Hautarzt; 2016 Aug; 67(8):627-34. PubMed ID: 27351559
[TBL] [Abstract][Full Text] [Related]
2. [Small fiber neuropathy as a possible cause for chronic pruritus].
Pereira MP; Mühl S; Ständer S
Hautarzt; 2016 Aug; 67(8):615-21. PubMed ID: 27315103
[TBL] [Abstract][Full Text] [Related]
3. [Topical therapy of pruritus-tips for daily practice].
Salzmann S; Staubach P
Hautarzt; 2020 Jul; 71(7):511-517. PubMed ID: 32399669
[TBL] [Abstract][Full Text] [Related]
4. S2k guideline: Diagnosis and treatment of chronic pruritus.
Ständer S; Zeidler C; Augustin M; Darsow U; Kremer AE; Legat FJ; Koschmieder S; Kupfer J; Mettang T; Metz M; Nast A; Raap U; Schneider G; Ständer H; Streit M; Schut C; Weisshaar E
J Dtsch Dermatol Ges; 2022 Oct; 20(10):1387-1402. PubMed ID: 36252071
[TBL] [Abstract][Full Text] [Related]
5. Medical treatment of pruritus.
Ständer S; Weisshaar E
Expert Opin Emerg Drugs; 2012 Sep; 17(3):335-45. PubMed ID: 22870909
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of chronic pruritus-what is new?].
Zeidler C; Metz M; Steinke S; Ständer S
Hautarzt; 2018 Aug; 69(8):641-646. PubMed ID: 29931387
[TBL] [Abstract][Full Text] [Related]
7. S2k Guidelines for the diagnosis and treatment of chronic pruritus - update - short version.
Ständer S; Zeidler C; Augustin M; Bayer G; Kremer AE; Legat FJ; Maisel P; Mettang T; Metz M; Nast A; Niemeier V; Raap U; Schneider G; Ständer HF; Staubach P; Streit M; Weisshaar E
J Dtsch Dermatol Ges; 2017 Aug; 15(8):860-872. PubMed ID: 28763584
[TBL] [Abstract][Full Text] [Related]
8. The NK1 receptor antagonist serlopitant for treatment of chronic pruritus.
Ständer S; Spellman MC; Kwon P; Yosipovitch G
Expert Opin Investig Drugs; 2019 Aug; 28(8):659-666. PubMed ID: 31272246
[No Abstract] [Full Text] [Related]
9. Antipruritic treatment with systemic μ-opioid receptor antagonists: a review.
Phan NQ; Bernhard JD; Luger TA; Ständer S
J Am Acad Dermatol; 2010 Oct; 63(4):680-8. PubMed ID: 20462660
[TBL] [Abstract][Full Text] [Related]
10. Chronic pruritus: targets, mechanisms and future therapies.
Pogatzki-Zahn E; Marziniak M; Schneider G; Luger TA; Ständer S
Drug News Perspect; 2008 Dec; 21(10):541-51. PubMed ID: 19221635
[TBL] [Abstract][Full Text] [Related]
11. Oral tacrolimus treatment of pruritus in prurigo nodularis.
Halvorsen JA; Aasebø W
Acta Derm Venereol; 2015 Sep; 95(7):866-7. PubMed ID: 25804254
[No Abstract] [Full Text] [Related]
12. [Treatment of chronic itch in systemic disease. Current standards].
Mettang T; Ständer S; Kremer AE
Internist (Berl); 2015 Dec; 56(12):1369-78. PubMed ID: 26585238
[TBL] [Abstract][Full Text] [Related]
13. [Therapy of prurigo nodularis].
Zeidler C; Ständer S
Hautarzt; 2014 Aug; 65(8):709-13. PubMed ID: 25113330
[TBL] [Abstract][Full Text] [Related]
14. Emerging drugs for the treatment of chronic pruritic diseases.
Fourzali K; Golpanian RS; Yosipovitch G
Expert Opin Emerg Drugs; 2020 Sep; 25(3):273-284. PubMed ID: 32715798
[TBL] [Abstract][Full Text] [Related]
15. [Pruritus in systemic diseases : Common and rare etiologies].
Kremer AE; Mettang T
Hautarzt; 2016 Aug; 67(8):606-14. PubMed ID: 27376752
[TBL] [Abstract][Full Text] [Related]
16. Treatments for chronic pruritus outside of the box.
Metz M
Exp Dermatol; 2019 Dec; 28(12):1476-1481. PubMed ID: 31310694
[TBL] [Abstract][Full Text] [Related]
17. Pruritus assessment in clinical trials: consensus recommendations from the International Forum for the Study of Itch (IFSI) Special Interest Group Scoring Itch in Clinical Trials.
Ständer S; Augustin M; Reich A; Blome C; Ebata T; Phan NQ; Szepietowski JC;
Acta Derm Venereol; 2013 Sep; 93(5):509-14. PubMed ID: 23624777
[TBL] [Abstract][Full Text] [Related]
18. [Antipruritic efficacy of a high-dosage antihistamine therapy. Results of a retrospectively analysed case series].
Schulz S; Metz M; Siepmann D; Luger TA; Maurer M; Ständer S
Hautarzt; 2009 Jul; 60(7):564-8. PubMed ID: 19430742
[TBL] [Abstract][Full Text] [Related]
19. Ondansetron and pruritus in chronic liver disease: a controlled study.
Jones EA; Molenaar HA; Oosting J
Hepatogastroenterology; 2007 Jun; 54(76):1196-9. PubMed ID: 17629069
[TBL] [Abstract][Full Text] [Related]
20. Emerging drugs for the treatment of pruritus.
Ständer S; Weisshaar E; Raap U
Expert Opin Emerg Drugs; 2015 Sep; 20(3):515-21. PubMed ID: 26027744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
